Dickinson Andrew D — SEC Form 4 filings
SEC reporting owner CIK 1310204. 41 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2024-01-17 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 29 legs across 27 filings — 617,430 shares, $61,384,033 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 80.
- Largest priced transaction: sale of 137,676 shares @ $102.22 ($14,073,241) in GILEAD SCIENCES, INC., filed 2025-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | Chief Financial Officer | 41 | — | 29 legs · 617,430 sh · $61,384,033 | 80 |
Form 4 filings — Dickinson Andrew D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $145.29 | EDGAR |
| 2026-09-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 2,797 · Tax withholding (F): 1,347 @ $144.81 · Option exercise (M): 2,797 (derivative) | EDGAR |
| 2026-08-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $138.36 | EDGAR |
| 2026-07-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $129.93 | EDGAR |
| 2026-06-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $125.40 | EDGAR |
| 2026-06-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 2,796 · Tax withholding (F): 1,341 @ $121.48 · Option exercise (M): 2,796 (derivative) | EDGAR |
| 2026-05-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $132.27 | EDGAR |
| 2026-04-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $140.96 | EDGAR |
| 2026-03-17 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $144.23 | EDGAR |
| 2026-03-12 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 6,469 · Tax withholding (F): 3,147 @ $148.56 · Option exercise (M): 6,469 (derivative) · Grant/award (A): 9,590 (derivative) · Grant/award (A): 35,880 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 11,090 @ $0 | EDGAR |
| 2026-02-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $154.43 | EDGAR |
| 2026-02-05 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 44,867 @ $0 · Tax withholding (F): 24,802 @ $143.28 | EDGAR |
| 2026-01-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $124.31 | EDGAR |
| 2025-12-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $122 | EDGAR |
| 2025-12-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,693 · Tax withholding (F): 1,745 @ $121.34 · Option exercise (M): 3,693 (derivative) | EDGAR |
| 2025-11-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $125.23 | EDGAR |
| 2025-10-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $118.08 | EDGAR |
| 2025-09-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $113.57 | EDGAR |
| 2025-09-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,696 · Tax withholding (F): 1,751 @ $115.25 · Option exercise (M): 3,696 (derivative) | EDGAR |
| 2025-08-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $118.53 | EDGAR |
| 2025-07-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $111.03 | EDGAR |
| 2025-06-17 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $110.17 | EDGAR |
| 2025-06-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,694 · Tax withholding (F): 1,758 @ $110.09 · Option exercise (M): 3,694 (derivative) | EDGAR |
| 2025-05-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $99.82 | EDGAR |
| 2025-04-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $106.40 | EDGAR |
| 2025-03-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $110.53 | EDGAR |
| 2025-03-12 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 4,916 @ $63.91 · Option exercise (M): 13,013 @ $63.91 · Sale (S): 4,916 @ $117.30 · Sale (S): 13,013 @ $118.50 · Option exercise (M): 7,968 · Tax withholding (F): 3,855 @ $117.21 · +5 more | EDGAR |
| 2025-02-19 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $104.09 | EDGAR |
| 2025-02-13 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 77,691 @ $63.91 · Option exercise (M): 26,175 @ $57.92 · Option exercise (M): 15,600 @ $80.72 · Option exercise (M): 18,210 @ $83.49 · Sale (S): 137,676 @ $102.22 · Option exercise (M): 77,691 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-06 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 19,793 @ $0 · Grant/award (A): 64,695 @ $0 · Tax withholding (F): 43,138 @ $97.99 | EDGAR |
| 2025-02-03 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 26,170 @ $57.92 · Option exercise (M): 71,850 @ $72.34 · Option exercise (M): 44,160 @ $65.38 · Sale (S): 142,180 @ $97.22 · Option exercise (M): 26,170 (derivative) @ $0 · Option exercise (M): 71,850 (derivative) @ $0 · +1 more | EDGAR |
| 2025-01-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 2,500 @ $91.35 | EDGAR |
| 2024-12-17 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 8,500 @ $91.96 | EDGAR |
| 2024-12-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,640 · Tax withholding (F): 1,686 @ $92.34 · Option exercise (M): 3,640 (derivative) | EDGAR |
| 2024-12-03 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 18,630 @ $73.77 · Option exercise (M): 26,170 @ $57.92 · Option exercise (M): 33,660 @ $68.75 · Option exercise (M): 60,885 @ $71.91 · Option exercise (M): 43,340 @ $72.70 · Option exercise (M): 65,960 @ $72.70 · +8 more | EDGAR |
| 2024-09-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,641 · Tax withholding (F): 1,682 @ $81.44 · Option exercise (M): 3,641 (derivative) | EDGAR |
| 2024-06-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,639 · Tax withholding (F): 1,662 @ $65.25 · Option exercise (M): 3,639 (derivative) | EDGAR |
| 2024-03-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,025 · Option exercise (M): 6,707 · Tax withholding (F): 4,505 @ $75.12 · Option exercise (M): 3,025 (derivative) · Option exercise (M): 6,707 (derivative) · Grant/award (A): 87,970 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-02 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 19,006 @ $0 · Grant/award (A): 55,955 @ $0 · Tax withholding (F): 23,410 @ $78.26 | EDGAR |
| 2024-01-17 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 5,000 @ $85.78 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1310204 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →